Genomic integrity and the genetics of cancer.
Tlsty
T D
TD
Lineberger Comprehensive Cancer Center, Department of Pathology, University of North Carolina at Chapel Hill 27599-7295, USA.
White
A
A
Livanos
E
E
Sage
M
M
Roelofs
H
H
Briot
A
A
Poulose
B
B
D017500:Adenovirus E1A Proteins / Q000235:genetics; D000260:Adenoviruses, Human / Q000235:genetics / Q000472:pathogenicity; D000963:Antimetabolites / Q000494:pharmacology; D017209:Apoptosis / Q000235:genetics; D001224:Aspartic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D002453:Cell Cycle / Q000187:drug effects / Q000235:genetics; D002478:Cells, Cultured; D004351:Drug Resistance / Q000235:genetics; D016158:Genes, p53; D015894:Genome, Human; D018095:Germ-Line Mutation; D006801:Humans; D016864:Li-Fraumeni Syndrome / Q000235:genetics; D009369:Neoplasms / Q000235:genetics*; D027383:Papillomaviridae / Q000235:genetics / Q000472:pathogenicity; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000494:pharmacology
D017500:Adenovirus E1A Proteins; D000963:Antimetabolites; D001224:Aspartic Acid; C013195:sparfosic acid; D010746:Phosphonoacetic Acid